Rezolute
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Rezolute and other ETFs, options, and stocks.About RZLT
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism.
CEONevan Charles Elam
CEONevan Charles Elam
Employees71
Employees71
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2010
Founded2010
Employees71
Employees71
RZLT Key Statistics
Market cap253.61M
Market cap253.61M
Price-Earnings ratio-2.93
Price-Earnings ratio-2.93
Dividend yield—
Dividend yield—
Average volume5.64M
Average volume5.64M
High today$2.92
High today$2.92
Low today$2.42
Low today$2.42
Open price$2.48
Open price$2.48
Volume7.19M
Volume7.19M
52 Week high$11.46
52 Week high$11.46
52 Week low$1.07
52 Week low$1.07
Stock Snapshot
As of today, Rezolute(RZLT) shares are valued at $2.69. The company's market cap stands at 253.61M, with a P/E ratio of -2.93.
On 2026-01-14, Rezolute(RZLT) stock traded between a low of $2.42 and a high of $2.92. Shares are currently priced at $2.69, which is +11.2% above the low and -7.8% below the high.
Rezolute(RZLT) shares are trading with a volume of 7.19M, against a daily average of 5.64M.
In the last year, Rezolute(RZLT) shares hit a 52-week high of $11.46 and a 52-week low of $1.07.
In the last year, Rezolute(RZLT) shares hit a 52-week high of $11.46 and a 52-week low of $1.07.
Analyst ratings
60%
of 10 ratingsBuy
60%
Hold
40%
Sell
0%
People also own
Based on the portfolios of people who own RZLT. This list is generated using Robinhood data, and it’s not a recommendation.